These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11845633)

  • 41. Direct-to-consumer advertisements of prescription drugs.
    Council on Ethical and Judicial Affairs of the American Medical Association
    Food Drug Law J; 2000; 55(1):119-24. PubMed ID: 12322719
    [No Abstract]   [Full Text] [Related]  

  • 42. Message strategies in direct-to-consumer pharmaceutical advertising: a content analysis using Taylor's six-segment message strategy wheel.
    Tsai WH; Lancaster AR
    Health Mark Q; 2012; 29(3):239-55. PubMed ID: 22905945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liability for adverse events in direct-to-consumer advertising.
    Shein D
    JAMA; 2003 May; 289(20):2646; author reply 2647. PubMed ID: 12771107
    [No Abstract]   [Full Text] [Related]  

  • 44. Liability for adverse events in direct-to-consumer advertising.
    Evans GW; Friede AI
    JAMA; 2003 May; 289(20):2646-7; author reply 2647. PubMed ID: 12771108
    [No Abstract]   [Full Text] [Related]  

  • 45. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
    Strawn MN
    J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255
    [No Abstract]   [Full Text] [Related]  

  • 46. The role of direct-to-consumer advertising.
    Navarro RP
    Manag Care Interface; 1998 Nov; 11(11):79-80, 82. PubMed ID: 10187419
    [No Abstract]   [Full Text] [Related]  

  • 47. FDA investigates direct to consumer adverts.
    Lenzer J
    BMJ; 2005 Nov; 331(7525):1102. PubMed ID: 16282396
    [No Abstract]   [Full Text] [Related]  

  • 48. A history of adverse drug experiences: Congress had ample evidence to support restrictions on the promotion of prescription drugs.
    Waxman HA
    Food Drug Law J; 2003; 58(3):299-312. PubMed ID: 14626231
    [No Abstract]   [Full Text] [Related]  

  • 49. Prescription drug advertising: is it a driving force on drug pricing?
    Millstein LG
    N C Med J; 2003; 64(6):289-91. PubMed ID: 14983621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The great American medicine show revisited.
    Tomes N
    Bull Hist Med; 2005; 79(4):627-63. PubMed ID: 16327082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New DTC guidelines please drug companies, anger critics.
    Med Health; 2005 Aug; 59(27):5-6. PubMed ID: 16111080
    [No Abstract]   [Full Text] [Related]  

  • 52. Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisements.
    Kaphingst KA; Rudd RE; DeJong W; Daltroy LH
    Patient Educ Couns; 2004 Nov; 55(2):293-300. PubMed ID: 15530767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The great debate over drug ads.
    Atkinson H
    Health News; 1999 Jun; 5(8):4. PubMed ID: 10397029
    [No Abstract]   [Full Text] [Related]  

  • 54. Direct-to-consumer advertising: helpful or harmful--or maybe both?
    La Puma J
    Manag Care; 1998 Apr; 7(4):72-3. PubMed ID: 10179359
    [No Abstract]   [Full Text] [Related]  

  • 55. The industry is tuning out on direct-to-consumer advertising.
    Mastroni N
    Med Mark Media; 1984 Jul; 19(7):10-1, 14-22. PubMed ID: 10267008
    [No Abstract]   [Full Text] [Related]  

  • 56. Off label drug promotion.
    Body Posit; 1998 Oct; 11(10):11. PubMed ID: 11365909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The patient's role in choice of medications: direct-to-consumer advertising and patient decision aids.
    Chin MH
    Yale J Health Policy Law Ethics; 2005; 5(2):771-84. PubMed ID: 16052899
    [No Abstract]   [Full Text] [Related]  

  • 58. MSJAMA: rethinking the role of the learned intermediary: the effect of direct-to-consumer advertising on litigation.
    Gemperli MP
    JAMA; 2000 Nov; 284(17):2241. PubMed ID: 11056600
    [No Abstract]   [Full Text] [Related]  

  • 59. AAFP supports improvement, not ban, on direct-to-consumer prescription drug ads.
    Kellerman R;
    Ann Fam Med; 2007; 5(2):180-1. PubMed ID: 17389544
    [No Abstract]   [Full Text] [Related]  

  • 60. Direct-to-consumer prescription drug advertising: trends, impact, and implications.
    Wilkes MS; Bell RA; Kravitz RL
    Health Aff (Millwood); 2000; 19(2):110-28. PubMed ID: 10718026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.